Did you know that your Internet Explorer is out of date?

To get the best possible experience using our website we recommend that you upgrade to another web browser. Outdated browsers don't follow the latest web standards, are full of bugs, don't offer the new browser features and may have security issues and malware. These browsers are normally no longer supported.

Please make use of one of the following links to upgrade you browser and website surfing experience. They are free to upgrade and you will have the advantage of having the new browser keep its self up to date as well as the latest features.

Google Chrome Mozilla Firefox

Short course in Clinical Management of Tuberculosis

30 Clinical Points Only R 1 997.37 (incl VAT)


Facebook Linkein Twitter

Introduction

South Africa is one of the 22 countries globally, that is designated by the WHO as a “TB hot spot” country. Six countries account for 60% of the total TB cases, with India leading the count, followed by Indonesia, China, Nigeria, Pakistan and South Africa. The number of TB cases reported in South Africa was relatively stable between 1980 and 1989. Fuelled by the rise in HIV prevalence, the number of TB cases increased from 68,027 TB cases (187/100,000) in 1989 to 188,695 TB cases (424/100,000) in 2001, an increase of 276% and a prevalence of 768 per 100 000 a decade later. The total cases notified in 2016 were 244,053 (new and relapse cases) with a TB/HIV incidence of 461/100,000.

In 2016 an estimated 1.3 million people who were HIV negative died of TB. In addition there were 374,000 deaths resulting from TB disease among people who were HIV positive. So there were a total of 1,674,000 TB related deaths.

An estimated 250,000 children died of TB in 2016 including children with HIV associated TB.

People who have both TB and HIV when they die, are internationally classified as having died from HIV. Forty percent of HIV deaths were due to TB.

In 2016 only 6.3 million cases of TB were reported, but there were globally an estimated 10.4 new cases of TB. So where are these “missing” four million? How can they be found and provided with treatment?

A serious complication to the Tuberculosis epidemic in South and southern Africa has been the emergence of multi-drug resistant (MDR) strains or extensively drug resistant TB (XDR TB).

Estimated WHO Regional TB statistics for 2016
WHO Region Total TB Mortality Male 0 - 14 Years TB Mortality Female 0 - 14 Years TB Mortality Male > 14 Years TB Mortality Female > 14 Years
Africa 320,000 23,000 20,000 177,000 100,000
Americas 6,200 1,000 0.860 2,900 1,500
Eastern Mediterranean 3,000 0.260 0.210 1,400 1,100
Europe 5,100 0.47 0.390 3,000 1,200
South-East Asia 35,000 2,400 0.20 20,000 9,900
Western Pacific 5,000 930 0.78 2,200 1,000
Global Total 374,000 28,000 24,000 207,000 115,000

https://www.tbfacts.org/tb-statistics/

SA has the means to overcome the TB epidemic situation and the following will have a substantial impact on TB control:

  • Implementation of the basics of TB diagnosis and treatment
  • Scaling up the use of Xpert MTB/RIF as a replacement for sputum smear microscopy
  • Strengthening case finding in and beyond healthcare facilities
  • TB prevention for people living with HIV, particularly earlier initiation of and scaling up antiretroviral therapy and scaling up continuous isoniazid preventive therapy
  • Introduction and the use of new TB drugs, diagnostics and vaccines to further accelerate progress towards improved TB control in SA and beyond.

Course Content

The following chapters are covered in this short course:

  • History, transmission and pathogenesis of tuberculosis
  • The global status and epidemiology of tuberculosis
  • The DOTS strategy and tuberculosis control programme
  • Diagnosis of tuberculosis
  • Clinical treatment of tuberculosis
  • Tuberculosis and HIV
  • Multidrug-resistant tuberculosis
  • Tuberculosis in children
  • Non-tuberculous mycobacteria
  • Health promotion and prevention strategies used in the control of tuberculosis
  • Managing tuberculosis at district level

Course Design

This is an online course. Participants have 3 months to complete the assessment process from date of registration.


Who Should Enrol

All healthcare professionals


Accreditation

Accredited according to HCPSA's Medical and Dental Board Guidelines for Healthcare Professionals for 30 Clinical CEU's on Level 2.


Certification

Your CPD certificate will be generated to your online CPD Manager, upon completion.


Course Fee

R 1 997.37 (This amount is inclusive of all vat and taxes where applicable)


Contact

For more information contact:

ILANA VAN DER MERWE / LODINE DE VILLIERS

Tel: 012 816 9099/9045
Fax: 086 558 9535
Email: ilanavdm@foundation.co.za or lodined@foundation.co.za

Address: P.O. Box 75324,
Lynnwood Ridge,
0040

Website: www.foundation.co.za


To access the product, please login or register to continue

Register